Catania, Italy

Marzia Buscema

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Universität Freiburg, University of Basel. Active years: 2024.


% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marzia Buscema: Innovator in Mechanosensitive Liposomes

Introduction

Marzia Buscema is a prominent inventor based in Catania, Italy. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of mechanosensitive liposomes. Her innovative work has the potential to enhance drug delivery systems and improve therapeutic outcomes.

Latest Patents

Marzia Buscema holds a patent for "Shear stress sensitive liposomes." This patent describes a liposome vesicle that comprises a membrane made of 1,3-diheptadecanamidopropan-2-yl(2-(trimethylammonio)ethyl)phosphate. The vesicle surrounds a volume containing a pharmaceutical drug or contrast agent. Notably, this vesicle is mechanosensitive at body temperature and under physiologically or pathophysiologically relevant shear stress.

Career Highlights

Throughout her career, Marzia has worked with esteemed institutions such as Universität Basel and Universität Freiburg. Her research has focused on the intersection of biophysics and pharmaceutical sciences, leading to advancements in drug delivery mechanisms.

Collaborations

Marzia has collaborated with notable colleagues, including Bert Müller and Andreas Zumbühl. These partnerships have fostered a rich environment for innovation and research in her field.

Conclusion

Marzia Buscema's work in mechanosensitive liposomes represents a significant advancement in pharmaceutical technology. Her contributions are paving the way for more effective drug delivery systems, showcasing her role as a leading inventor in this innovative field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…